Lensar (LNSR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.80, -3.81% vs the prior close of $6.03.
- Volume 76.45K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LNSR slides 3.8% to $5.80, a 1-month low, 3 down days in a row. Closed at $5.80, -3.81% vs the prior close of $6.03. Day range $5.80–$6.16, opened at $6.03.
LNSR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LNSR slides 3.8% to $5.80, a 1-month low, 3 down days in a row
- Closed at $5.80, -3.81% vs the prior close of $6.03. Day range $5.80–$6.16, opened at $6.03.
- Volume was 76.45K shares, 0.6x its 50-day average of 121.14K.
- Price is -21.7% vs its 50-day average ($7.41) and -25.0% vs its 200-day average ($7.74).
- 52-week range $4.95–$12.94; today's close sits at 11% of that range, 55.2% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — LNSR dips 1.3% to $6.03, a 1-month low
- Closed at $6.03, -1.31% vs the prior close of $6.11. Day range $6.03–$6.24, opened at $6.11.
- Volume was 41.40K shares, 0.3x its 50-day average of 120.61K — lighter than usual.
- Price is -18.6% vs its 50-day average ($7.41) and -22.4% vs its 200-day average ($7.77).
- 52-week range $4.95–$12.94; today's close sits at 14% of that range, 53.4% below the 52-week high.
Oct 14, 2026 — LNSR dips 2.6% to $6.11, a 1-month low
- Closed at $6.11, -2.55% vs the prior close of $6.27. Day range $6.07–$6.32, opened at $6.22.
- Volume was 44.70K shares, 0.4x its 50-day average of 120.67K — lighter than usual.
- Price is -17.5% vs its 50-day average ($7.40) and -21.6% vs its 200-day average ($7.80).
- 52-week range $4.95–$12.94; today's close sits at 15% of that range, 52.8% below the 52-week high.
Oct 13, 2026 — LNSR rises 0.8% to $6.27
- Closed at $6.27, +0.80% vs the prior close of $6.22. Day range $6.20–$6.32, opened at $6.21.
- Volume was 23.90K shares, 0.2x its 50-day average of 121.13K — lighter than usual.
- Price is -15.2% vs its 50-day average ($7.39) and -19.9% vs its 200-day average ($7.82).
- 52-week range $4.95–$12.94; today's close sits at 17% of that range, 51.5% below the 52-week high.
Oct 12, 2026 — LNSR dips 2.4% to $6.22, a 1-month low, 4 down days in a row
- Closed at $6.22, -2.35% vs the prior close of $6.37. Day range $6.17–$6.38, opened at $6.38.
- Volume was 43.80K shares, 0.4x its 50-day average of 122.47K — lighter than usual.
- Price is -15.7% vs its 50-day average ($7.37) and -20.8% vs its 200-day average ($7.85).
- 52-week range $4.95–$12.94; today's close sits at 16% of that range, 51.9% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — LNSR dips 1.2% to $6.37, a 1-month low, 3 down days in a row
- Closed at $6.37, -1.24% vs the prior close of $6.45. Day range $6.37–$6.54, opened at $6.43.
- Volume was 15.30K shares, 0.1x its 50-day average of 122.74K — lighter than usual.
- Price is -13.3% vs its 50-day average ($7.35) and -19.2% vs its 200-day average ($7.88).
- 52-week range $4.95–$12.94; today's close sits at 18% of that range, 50.8% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — LNSR dips 0.9% to $6.45, a 1-month low
- Closed at $6.45, -0.92% vs the prior close of $6.51. Day range $6.37–$6.51, opened at $6.50.
- Volume was 24.80K shares, 0.2x its 50-day average of 123.12K — lighter than usual.
- Price is -12.0% vs its 50-day average ($7.33) and -18.5% vs its 200-day average ($7.91).
- 52-week range $4.95–$12.94; today's close sits at 19% of that range, 50.2% below the 52-week high.
Oct 7, 2026 — LNSR dips 2.8% to $6.51, a 1-month low
- Closed at $6.51, -2.84% vs the prior close of $6.70. Day range $6.50–$6.66, opened at $6.65.
- Volume was 32.30K shares, 0.3x its 50-day average of 123.04K — lighter than usual.
- Price is -10.8% vs its 50-day average ($7.30) and -18.0% vs its 200-day average ($7.94).
- 52-week range $4.95–$12.94; today's close sits at 20% of that range, 49.7% below the 52-week high.
Oct 6, 2026 — LNSR rises 0.4% to $6.70
- Closed at $6.70, +0.45% vs the prior close of $6.67. Day range $6.58–$6.80, opened at $6.66.
- Volume was 33.90K shares, 0.3x its 50-day average of 123.35K — lighter than usual.
- Price is -8.0% vs its 50-day average ($7.28) and -15.9% vs its 200-day average ($7.97).
- 52-week range $4.95–$12.94; today's close sits at 22% of that range, 48.2% below the 52-week high.
Oct 5, 2026 — LNSR dips 1.2% to $6.67
- Closed at $6.67, -1.19% vs the prior close of $6.75. Day range $6.67–$6.85, opened at $6.73.
- Volume was 51.50K shares, 0.4x its 50-day average of 123.81K — lighter than usual.
- Price is -8.0% vs its 50-day average ($7.25) and -16.5% vs its 200-day average ($7.99).
- 52-week range $4.95–$12.94; today's close sits at 22% of that range, 48.5% below the 52-week high.
Oct 2, 2026 — LNSR rises 2.7% to $6.75
- Closed at $6.75, +2.74% vs the prior close of $6.57. Day range $6.55–$6.87, opened at $6.57.
- Volume was 69.80K shares, 0.6x its 50-day average of 123.32K — lighter than usual.
- Price is -6.7% vs its 50-day average ($7.23) and -15.8% vs its 200-day average ($8.02).
- 52-week range $4.95–$12.94; today's close sits at 23% of that range, 47.8% below the 52-week high.
LNSR latest news & SEC filings
Every SEC filing by or about LNSR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $14.72M (prior year $12.29M) (+19.8% vs Jun 30, 2025)
- Net income: $3.54M (prior year -$1.76M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.10 (prior year -$0.15) (swung to profit vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 23, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 23, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Jun 23, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade LNSR
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 8, 2026, Mar 31, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.65% (largest 4.5%).
- Liquidity: about 38.17K shares (≈$221.40K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $5.80 vs a range of $4.95–$12.94 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 8-K Aug 10, 2026.
- Share count: 12.29M shares outstanding (Jul 31, 2026), +2.9% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
LNSR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.03 | 6.16 | 5.80 | 5.80 | 76.45K |
| Oct 15, 2026 | 6.11 | 6.24 | 6.03 | 6.03 | 41.40K |
| Oct 14, 2026 | 6.22 | 6.32 | 6.07 | 6.11 | 44.70K |
| Oct 13, 2026 | 6.21 | 6.32 | 6.20 | 6.27 | 23.90K |
| Oct 12, 2026 | 6.38 | 6.38 | 6.17 | 6.22 | 43.80K |
| Oct 9, 2026 | 6.43 | 6.54 | 6.37 | 6.37 | 15.30K |
| Oct 8, 2026 | 6.50 | 6.51 | 6.37 | 6.45 | 24.80K |
| Oct 7, 2026 | 6.65 | 6.66 | 6.50 | 6.51 | 32.30K |
| Oct 6, 2026 | 6.66 | 6.80 | 6.58 | 6.70 | 33.90K |
| Oct 5, 2026 | 6.73 | 6.85 | 6.67 | 6.67 | 51.50K |
| Oct 2, 2026 | 6.57 | 6.87 | 6.55 | 6.75 | 69.80K |
| Oct 1, 2026 | 6.58 | 6.80 | 6.50 | 6.57 | 40.90K |
| Sep 30, 2026 | 6.95 | 6.95 | 6.59 | 6.59 | 35.70K |
| Sep 29, 2026 | 6.85 | 6.95 | 6.78 | 6.90 | 25.80K |
| Sep 28, 2026 | 6.92 | 6.97 | 6.79 | 6.88 | 34.80K |
| Sep 25, 2026 | 7.06 | 7.15 | 6.92 | 6.92 | 22.80K |
| Sep 24, 2026 | 7.15 | 7.17 | 6.98 | 7.07 | 17.60K |
| Sep 23, 2026 | 7.26 | 7.26 | 6.97 | 7.15 | 28.30K |
| Sep 22, 2026 | 7.24 | 7.30 | 7.15 | 7.25 | 29.20K |
| Sep 21, 2026 | 7.06 | 7.25 | 6.99 | 7.21 | 70.50K |
About Lensar
Lensar (LNSR) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ORLANDO, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1320350.
LNSR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Nicholas T Curtis | Chief Executive Officer | Jun 5, 2026 |
| Thomas B Ellis | Director | Jun 5, 2026 |
| Todd B Hammer | Director | Jun 5, 2026 |
| Richard L Md Lindstrom | Director | Jun 5, 2026 |
| William J Phd Link | Director | Jun 5, 2026 |
| Elizabeth G. O'Farrell | Director | Jun 5, 2026 |
| Aimee S Weisner | Director | Jun 5, 2026 |
| Gary M Winer | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nicholas T Curtis | Chief Executive Officer | Jun 5, 2026 |
| Alan B. Connaughton | Chief Operating Officer | Jun 5, 2026 |
| Michael A. Rossi | Interim CFO | Jun 5, 2026 |
| Thomas R Ii Staab | Chief Financial Officer | May 8, 2026 |
| Kendra Wong | Principal Accounting Officer | Jun 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LNSR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $51.66M | $-34.28M | -2.87 | $-14.83M |
| Dec 31, 2024 | $45.96M | $-31.40M | -2.73 | $-2.27M |
| Dec 31, 2023 | $35.72M | $-14.38M | -1.31 | $-9.66M |
| Dec 31, 2022 | $29.44M | $-19.91M | -1.96 | $-14.86M |
| Dec 31, 2021 | $29.49M | $-19.60M | -2.09 | $-8.97M |
Latest balance sheet: total assets $69.56M, total liabilities $40.87M, cash $13.56M (as of Jun 30, 2026).
LNSR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $8.27 |
| May 8, 2026 | 8-K Item 2.02 (results) | $5.64 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $5.96 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $11.44 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $12.84 |
| May 8, 2025 | 8-K Item 2.02 (results) | $13.81 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $10.87 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $6.87 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 4, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LNSR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.